Preclinical Development of ARV-2001, an Intradermally Administered mRNA-Lipid Nanoparticle Immunotherapeutic for the Treatment of HPV-16-Positive Cervical High-Grade Squamous Intraepithelial Lesions.

Zyclara (imiquimod) - Mochida, Viatris, Bausch Health

http://www.ncbi.nlm.nih.gov/pubmed/42646731

Gregory M Glenn; Huabin Zhu; Jianzhu Chen; Ju Hyeong Jeon; Renhuan Xu; Zhengxiang He

Aug 27, 2026